Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page footer as part of a site update.
    Difference
    0.1%
    Check dated 2026-04-16T11:20:19.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Page revision history updated: v3.4.3 was removed and v3.5.0 was added.
    Difference
    0.1%
    Check dated 2026-03-18T20:31:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:36:19.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior notice about government funding and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:28:20.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:51:34.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC/version labels to 'Last Update Submitted that Met QC Criteria' with revision v3.4.0; removed the older 'Last Update Submitted that met QC Criteria' phrasing, removed the 'No FEAR Act data' note, and dropped the previous v3.3.4 reference.
    Difference
    0.2%
    Check dated 2026-01-28T04:20:55.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.